Light retardance lower in NAION eyes

January 15, 2014

Article

Patients with optic disc swelling caused by nonarteritic anterior ischaemic optic neuropathy (NAION) have less light retardance compared with patients with optic disc swelling caused by papilloedema or optic neuritis.

For this cross-sectional study, researchers set out to compare retinal nerve fibre layer thickness (RNFLT) in patients with optic disc swelling of different etiologies, and included a total of 47 patients. Scanning laser polarimetry (SLP; enhanced corneal compensation) and spectral-domain optical coherence tomography (OCT) RNFLT measurements were done in 19 eyes with papilloedema, 10 eyes with optic neuritis, and 18 eyes with NAION.

They found no statistical differences on average OCT-RNFLT in papilloedema, optic neuritis, and NAION. The average SLP-RNFLT in patients with NAION was smaller compared with that measured in patients with papilloedema (P P = 0.02).

Comparisons of RNFLT in each retinal quadrant reveled no difference among the etiological groups upon OCT; upon SLP comparisons, however, the superior quadrant was found to be thinner in NAION patients compared with papilloedema or optic neuropathy patients (P P

Superior SLP-RNFLT in patients with NAION was smaller (P = 0.026). The ratio of average SLP-RNFLT to average OCT-RNFLT was smaller in patients with NAION compared with papilloedema (P = 0.001).

For more information on this study, click here.

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Subscribe Now!

Recent Videos

At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients

Early intervention is crucial for long-term outcomes in paediatric gene therapy

$At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery$

Robert Ang, MD, explains why a small-aperture IOL is "not a niche product"

Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.

ARVO 2025: Ocular and systemic mitochondrial diseases may be key to dementia diagnosis

Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).

ARVO 2025: Alfredo Sadun, MD, PhD, says "later is better" for some LHON interventions

At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.

ARVO 2025: Nitish Mehta, MD, provides real-world insights from aflibercept 8 mg for treatment-naive diabetic macular oedema

ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy

ARVO 2025: Anat Loewenstein, MD, and colleagues on meeting needs of patients with diabetic retinopathy

$At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study$

Sheng Lim, MD, FRCOphth, brings data from the CONCEPT study to the ASCRS meeting